[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100566699":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":25,"centralContacts":30,"locations":40,"responsibleParty":60,"collaborators":63,"id":66,"slug":67,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":71,"acronym":24,"eligibilityCriteria":72,"healthyVolunteers":68,"sex":73,"minAge":74,"maxAge":24,"enrollmentInfo":75,"targetDuration":24,"studyType":78,"phases":79,"briefSummary":81,"conditions":82,"keywords":88,"overallStatus":43,"whyStopped":24,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":102},{"fullName":5,"class":6},"Rutgers, The State University of New Jersey","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Oral acetaminophen - Tablet","EXPERIMENTAL","Acetaminophen 650 mg tablet by mouth",[13],"Drug: Acetaminophen",{"label":15,"type":10,"description":16,"interventionNames":17},"Oral acetaminophen - Liquid","Acetaminophen 650 mg liquid by mouth",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"DRUG","Acetaminophen","Arm 1: Once cleared for oral intake - acetaminophen tablets 650 mg PO every 6 hours PRN - mild pain (1 - 3) to a maximum of 4 grams daily for 3 days\\' dispensed as unit-dose tablets Arm 2: Once cleared for oral intake - acetaminophen liquid (160 mg\u002F5 mL) 650 mg PO every 6 hours PRN - mild pain (1 - 3) to a maximum of 4 grams daily for 3 days; 650 mg = 20.3 mL, dispensed as a unit-dose cup",[15,9],null,[26],{"name":27,"affiliation":28,"role":29},"Daniel T Abazia, PharmD, BCPS, CPPS","Rutgers University - Ernest Mario School of Pharmacy","PRINCIPAL_INVESTIGATOR",[31,36],{"name":32,"role":33,"phone":34,"phoneExt":24,"email":35},"Daniel T Abazia, PharmD","CONTACT","773-633-5215","dabazia@pharmacy.rutgers.edu",{"name":37,"role":33,"phone":38,"phoneExt":24,"email":39},"Mindy Rodden, PhD, RN, CPNP-AC","732-418-8078","minnette.markus-rodden@rwjbh.org",[41],{"facility":42,"status":43,"city":44,"state":45,"zip":46,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"Robert Wood Johnson University Hospital","RECRUITING","New Brunswick","New Jersey","08690","United States","US",{"type":50,"coordinates":51},"Point",[52,53],-74.45182,40.48622,{"lat":53,"lon":52},[56,59],{"name":57,"role":33,"phone":34,"phoneExt":24,"email":58},"Daniel Abazia, PharmD, BCPS, CPPS","daniel.abazia@rwjbh.org",{"name":37,"role":33,"phone":38,"phoneExt":24,"email":39},{"type":29,"investigatorFullName":61,"investigatorTitle":62,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"Daniel T. Abazia, PharmD","Clinical Associate Professor",[64],{"name":65,"class":6},"Rutgers Robert Wood Johnson Medical School","100566699","phase-2-oral-acetaminophen-for-post-op-pain-management-in-bariatric-surgery-patients-100566699",false,"NCT06658574","Oral Acetaminophen for Post-Op Pain Management in Bariatric Surgery Patients","Comparative Efficacy of Two Different Oral Dosage Forms of Acetaminophen for Post-operative Analgesia in Bariatric Surgery Patients","Inclusion Criteria:\n\n* Adults aged 18 years old or greater who meet patient selection criteria for either primary Roux-en-Y gastric bypass or primary laparoscopic sleeve gastrectomy.\n\nExclusion Criteria:\n\n* Patients with a known hypersensitivity or history of intolerance to acetaminophen or any inactive ingredients in either formulation. Patients uncomfortable with or unable to take pills.\n* Surgical: Duodenal Switch (DS) surgeries, Adjustable Gastric Banding (AGB), surgical revisions, and surgical conversions.\n* Medical: patients with documented history of chronic and\u002For current pain syndrome, as evidenced by documentation of ICD-10 code G89.4, patients with documented ICD-10 code F11.90, indication unspecified, uncomplicated opioid use.\n* Patients of vulnerable populations, as outlined by federal guidelines as children, prisoners, pregnant women, and mentally disabled persons will be excluded.","ALL","18 Years",{"count":76,"type":77},150,"ESTIMATED","INTERVENTIONAL",[80],"PHASE2","Adult patients with morbid obesity who have had Roux-en-Y gastric bypass (RYGB) or laparoscopic sleeve gastrectomy (LSG) surgery have impaired drug metabolism. There is a paucity of information available on how these patients metabolize acetaminophen post operatively and if drug preparation has any effect on achieving adequate pain control. The surgery may alter the stomach pH, reduce surface area of the stomach, affect transit time, and alter anatomic and physiologic standard absorption of medications. Due to these anatomic and physiologic changes, we seek to understand the potential effects of liquid versus pill formulations of acetaminophen on pain control in this patient population. The purpose of this study is to assess for subjective and objective measures of optimized pain control between formulations of acetaminophen including oral pills and oral liquid.",[83,84,85,86,87],"Post Operative Analgesia","Bariatric Surgery","Bariatric Surgery (Gastric Bypass)","Bariatric Surgery Patients","Perioperative Analgesia",[21,89,90,91,92],"Bariatric","Analgesia","Perioperative","Post Operative","2025-04-01",{"date":95,"type":96},"2025-04-02","ACTUAL",{"date":98,"type":96},"2024-11-13",{"date":100,"type":77},"2026-05",{"name":5,"class":6},1]